Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian Adams currently holds 8,250 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Adams has been a net seller of RLAY stock. They have purchased $200.0K and sold $1.9M worth of shares.
Brian Adams's most recent insider trade was on Mar 2, 2026, when they sold 8,250 shares at $0.00 per share.
Brian Adams serves as Executive at Relay Therapeutics, Inc. (RLAY). They have executed 72 insider transactions totaling $2.1M over their tenure at the company.
Brian Adams holds the position of Executive at Relay Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Brian Adams has shown a selling trading pattern, with $200.0K in total purchases and $1.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brian Adams was on Jan 28, 2021, when they sold $275.3K worth of RLAY shares. This transaction involved 5,000 shares at $55.05 per share.
Brian Adams currently owns 8,250 shares of Relay Therapeutics, Inc. (RLAY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian Adams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian Adams has 72 Form 4 filings on record as an insider at Relay Therapeutics, Inc..
Set alerts for Brian Adams and 40,000+ other insiders.